Heineman Thomas Charles
SEC insider (Form 3/4/5 filer). CIK 0002103579. Chief Medical Officer at ONCOLYTICS BIOTECH INC (ONCY). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.
Companies Heineman Thomas Charles has filed insider reports for
- ONCOLYTICS BIOTECH INC (ONCY): Officer, Chief Medical Officer
Heineman Thomas Charles
CIK: 0002103579
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ONCY
ONCOLYTICS BIOTECH INC
Officer